Advertisement
Screener

FOXO TECHNOLOGIES INC. (FOXO) Graph

2.5 / 5 stars · 14/28 Roast Me

Add as a preferred source on Google

FOXO Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $4.72M; Cost of revenue (m); Research and development $23.70K; Selling, general and administrative $2.68M.
  • 2026-03-31: Revenue $5.17M; Cost of revenue (m); Research and development $35.55K; Selling, general and administrative $2.88M.
  • 2025-12-31: Revenue $4.43M*; Cost of revenue (m); Research and development $35.22K*; Selling, general and administrative $3.50M*.
  • 2025-09-30: Revenue $3.55M; Cost of revenue (m); Research and development $77.10K; Selling, general and administrative $2.47M.

Consolidation item

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

FOXO revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Operating Segments$4.72MRevenue$4.72MOperating expenses-$4.03MOperating income$8.75MOther income, net-$949.09KResearch & development$23.70KSelling, general& administrative$2.68MPre-tax income$8.14M

Segment

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

FOXO revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Health Cares$4.47MLabs$6.20KLife Science Services$238.46KRevenue$4.72MOperating expenses-$4.03MOperating income$8.75MOther income, net-$949.09KResearch & development$23.70KSelling, general& administrative$2.68MPre-tax income$8.14M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesNet income
2026-06-30$4.72M(m)$23.70K$2.68M-$4.03M$8.14M
2026-03-31$5.17M(m)$35.55K$2.88M$5.44M-$1.45M
2025-12-31$4.43M*(m)$35.22K*$3.50M*$12.92M*-$9.42M*
2025-09-30$3.55M(m)$77.10K$2.47M$4.41M-$1.88M
2025-06-30$5.22M(m)$40.18K$2.62M$4.65M-$522.02K
2025-03-31$3.17M(m)$30.00K$2.76M$4.72M-$616.46K
2024-09-30$1.20M(m)$43.81K$1.73M$2.20M-$1.95M
2024-06-30$27.47K(m)$103.10K$1.47M$1.62M-$2.16M
2024-03-31$7.18K(m)$165.36K$987.94K$1.19M-$1.50M
2023-09-30$10.00K$70.00K$283.00K$4.72M$3.45M-$3.66M
2023-06-30$12.00K$12.00K$333.00K$4.00M$7.62M-$11.29M
2023-03-31$13.00K$13.00K$309.00K$6.33M$7.41M-$7.64M
2022-09-30$14.00K$14.00K$558.00K$8.27M$8.83M-$41.03M
2022-06-30$39.00K$39.00K$1.00M$4.97M$5.97M-$23.54M
2022-03-31$40.00K$40.00K$601.00K$4.00M$4.60M-$12.37M
2021-09-30$31.00K$31.00K$1.67M$2.72M$4.39M-$27.24M
2021-06-30(m)(m)(m)(m)(m)-$1.86M
2021-03-31(m)(m)(m)(m)(m)$5.00M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesNet income
2026-06-30$9.88M(m)$59.25K$5.55M$1.41M$6.69M
2025-06-30$8.39M(m)$70.18K$5.38M$9.37M-$1.14M
2024-06-30$34.65K(m)$268.46K$2.46M$2.80M-$3.67M
2023-06-30$25.00K$25.00K$642.00K$10.34M$15.02M-$18.93M
2022-06-30$79.00K$79.00K$1.60M$8.97M$10.57M-$35.91M
2021-06-30(m)(m)(m)(m)(m)$3.14M

Revenue and expense 8 month

Period endNet income
2020-12-31-$1.78M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesNet income
2025-09-30$11.94M(m)$147.28K$7.86M$13.78M-$3.01M
2024-09-30$1.23M(m)$312.27K$4.20M$5.00M-$5.61M
2023-09-30$35.00K$70.00K$925.00K$15.05M$18.47M-$22.59M
2022-09-30$93.00K$93.00K$2.16M$17.24M$19.40M-$76.93M
2021-09-30$93.00K$93.00K$4.32M$7.64M$11.96M-$37.61M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$16.37M(m)$182.50K$11.36M$26.70M-$182.83K-$12.43M
2024-12-31$4.05M(m)$312.27K$7.23M$11.81M(m)-$12.41M
2023-12-31$145.29K$132.00K$900.43K$19.40M$22.33M(m)-$26.45M
2022-12-31$511.00K$344.00K$3.05M$25.83M$40.33M(m)-$95.25M
2021-12-31$120.00K$120.00K$4.88M$10.27M$15.15M(m)-$38.49M

Similar stocks

Stock NameCountryMarket CapPE Ratio
iSpecimen Inc. (ISPC)United States$0.003B
OneMedNet Corp (ONMD)$0.042B
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
NRC HEALTH (NRC)United States$0.450B42.50
OmniAb, Inc. (OABI)United States$0.698B-8.05
Absci Corp (ABSI)United States$1.775B-14.92
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14
Advertisement